Century Therapeutics (IPSC) Reddit Discussion Analysis: T1D Cure Potential & Risk-Reward Assessment

On November 23, 2025 (EST), a Reddit post discussed Century Therapeutics (IPSC) as a high-risk-reward investment due to its T1D cure potential using iPSC-derived islet cells with immune-evasion technology [5]. The stock trades at $0.49 with a $42.17M market cap [0]. Analyst consensus shows 15 analysts with a $14 target price (2757% upside) [1]. CEO Brent Pfeiffenberger bought 35,000 shares at $0.50 on November 19 [2]. The company announced CNTY-813 (iPSC beta islets for T1D) on November 13 [3].

1. Reddit sentiment is bullish (speculative 1500x-4000x upside) but contrasts with a 1-year price decline of 62.31% [1,5].
2. A high current ratio (10.72) suggests strong liquidity, though explicit cash reserves vs. market cap data is missing [1].
3. Insider buying aligns with analyst bullishness, signaling management confidence in the T1D program [1,2].

: Long-term downward trend (-62.31% 1Y), negative EPS (-$0.32 TTM), and speculative upside claims from Reddit [1,5]. Biotech execution and regulatory risks are significant for early-stage companies without revenue [1].
: T1D cure potential with iPSC technology, analyst consensus upside, and recent CEO insider buying [1,2,3].

• Current price: $0.49 [0]
• Analyst consensus: $14 target price (2757% upside) [1]
• Recent developments: CNTY-813 announcement (Nov 13), CEO insider purchase (Nov19) [2,3]
• Risks: Historical underperformance, negative financials, speculative claims [1,5]